Moderna Reports Third Quarter 2025 Financial Results and Provides Business Updates

Core Insights - Moderna, Inc. reported third quarter revenue of $1.0 billion, with a GAAP net loss of $(0.2) billion and a GAAP EPS of $(0.51) [1] - The company narrowed its 2025 projected revenue range to $1.6 - $2.0 billion [1] - Expected GAAP operating expenses for 2025 were improved by $0.7 billion to a range of $5.2 - $5.4 billion [1] - The expected year-end cash balance for 2025 was increased by $0.5 billion - $1 billion to a range of $6.5 - $7.0 billion [1] - CEO Stéphane Bancel highlighted strong commercial and financial performance in Q3, driven by COVID vaccine sales and cost-reduction initiatives [1]